WHO Drug Information

About WHO Drug Information

WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers.

Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers, consumer bodies, and pharmaceutical manufacturers and focuses on topics impacting the safety, efficacy and quality of medicines, medical products, herbals and biomedicines. It presents a range of perspectives on how current challenges impact the manufacture, prescribing and access of medicines throughout the world and introduces newly-released guidance documents.

For enquiries, please send an e-mail to druginfo@who.int

Information developed by WHO:

Guidelines and recommendations concerning medicines, biologicals, vaccines, medical devices, herbals and related products

Subscription

Subscription information:

WHO Drug Information provides an overview of topics relating to drug development and regulation that are of current relevance and importance, and includes the lists of proposed and recommended International Nonproprietary Names for Pharmaceutical Substances (INN).

WHO Drug Information is published 4 times a year.

To subscribe, please send an e-mail to druginfo@who.int

or order from

WHO Book orders